# MAIA (Maia Biotechnology, Inc.) - SEC EDGAR Financial Statements

> Maia Biotechnology, Inc. reported $22.10M in total assets and a net loss of $25.12M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MAIA
- Markdown: https://convexityos.com/fundamentals/MAIA.md
- SEC CIK: 0001878313
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001878313&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$27.61M | Operating profit |
| Net Income | FY 2025 | -$25.12M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.41 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $0 | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $0 | $0 | $0 | -- |
| Research & Development | $454K | $10.01M | $11.11M | $8.93M | $3.50M |
| Total Operating Expenses | $24.27M | $16.96M | $20.18M | $16.18M | $7.79M |
| **Operating Income** | -$24.27M | -$16.96M | -$20.18M | -$16.18M | -$7.79M |
| Interest Income | -- | $318K | $34K | $1.9K | $2.0K |
| Interest Expense | -- | $57 | $6.9K | $7.0K | $828K |
| Income Before Tax | -$22.39M | -$23.25M | -$19.80M | -$15.80M | -$12.60M |
| Income Tax Expense | $2.0K | $2.0K | -- | -- | -- |
| **Net Income** | -$22.40M | -$23.25M | -$19.77M | -$16.22M | -$12.50M |
| Basic EPS | -$0.70 | -$1.05 | -$1.49 | -$1.75 | -$2.37 |
| **Diluted EPS** | -$0.70 | -$1.05 | -$1.49 | -$1.75 | -$2.37 |
| Basic Shares Outstanding | 32.1M | 22.2M | 13.3M | 9.3M | 5.3M |
| Diluted Shares Outstanding | 32.1M | 22.2M | 13.3M | 9.3M | 5.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $5.34M | $179K | $44K | $1.88M | $6.36M | -$3.17M | $3.20M | $2.97M |
| Total Operating Expenses | $8.02M | $8.32M | $6.95M | $4.32M | $9.36M | $5.17M | $5.43M | $5.00M |
| **Operating Income** | -$8.02M | -$8.32M | -$6.95M | -$4.32M | -$9.36M | -$5.17M | -$5.43M | -$5.00M |
| Interest Income | -- | -- | -- | -- | -- | $80K | $82K | $80K |
| Income Tax Expense | -- | -- | $339 | $2.0K | $0 | $0 | $0 | $2.0K |
| **Net Income** | -$7.18M | -$7.94M | -$6.37M | -$3.63M | -$8.90M | -$5.35M | -$4.52M | -$3.57M |
| Basic EPS | -$0.12 | -$0.13 | -$0.14 | -- | -$0.27 | -$0.18 | -$0.16 | -- |
| **Diluted EPS** | -$0.12 | -$0.13 | -$0.14 | -- | -$0.27 | -$0.18 | -$0.16 | -- |
| Basic Shares Outstanding | 60.9M | 60.8M | 45.2M | -- | 33.2M | 30.3M | 27.7M | -- |
| Diluted Shares Outstanding | 60.9M | 60.8M | 45.2M | -- | 33.2M | 30.3M | 27.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $0 | $0 | $0 | $0 | $0 |
| **Cash & Short-Term Investments** | $0 | $0 | $0 | $0 | $0 |
| **Total Current Assets** | $9.70M | $10.15M | $7.56M | $11.81M | $10.67M |
| Other Non-Current Assets | $2.8K | $2.8K | $2.8K | $2.8K | $3.1K |
| **Total Non-Current Assets** | $2.8K | $2.8K | $2.8K | $214K | $655K |
| **Total Assets** | $9.70M | $10.16M | $7.57M | $12.02M | $11.33M |
| Accounts Payable | $2.04M | $1.51M | $1.64M | $1.17M | $960K |
| **Total Current Liabilities** | $5.84M | $3.83M | $4.94M | $3.27M | $2.15M |
| **Total Non-Current Liabilities** | $1.49M | $2.69M | $2.15M | $245K | $0 |
| **Total Liabilities** | $7.33M | $6.52M | $7.09M | $3.51M | $2.15M |
| Common Stock | $3.9K | $2.6K | $1.7K | $1.1K | $758 |
| Retained Earnings | -$109.6M | -$87.23M | -$63.98M | -$44.21M | -$28.44M |
| Accumulated Other Comp. Income | -$50K | -$31K | -$16K | -$16K | -- |
| **Total Stockholders' Equity** | $2.38M | $3.63M | $478K | -- | -- |
| Total Equity | $2.38M | $3.63M | $478K | $8.51M | $9.18M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Cash & Short-Term Investments** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Current Assets** | $22.10M | $28.24M | $35.32M | $9.70M | $11.75M | $11.04M | $11.86M | $10.15M |
| Other Non-Current Assets | $2.8K | $2.8K | $7.5K | $2.8K | $27K | $2.8K | $2.8K | $2.8K |
| **Total Non-Current Assets** | $2.8K | $2.8K | $7.5K | $2.8K | $27K | $2.8K | $2.8K | $2.8K |
| **Total Assets** | $22.10M | $28.24M | $35.32M | $9.70M | $11.78M | $11.05M | $11.86M | $10.16M |
| Accounts Payable | $4.12M | $2.84M | $2.98M | $2.04M | $3.18M | $1.72M | $1.84M | $1.51M |
| **Total Current Liabilities** | $6.47M | $6.26M | $6.32M | $5.84M | $9.99M | $5.04M | $5.06M | $3.83M |
| **Total Non-Current Liabilities** | $957K | $1.31M | $1.24M | $1.49M | $1.75M | $2.13M | $1.86M | $2.69M |
| **Total Liabilities** | $7.43M | $7.57M | $7.56M | $7.33M | $11.74M | $7.17M | $6.92M | $6.52M |
| Common Stock | $6.2K | $6.1K | $6.1K | $3.9K | $3.4K | $3.2K | $3.0K | $2.6K |
| Retained Earnings | -$131.1M | -$123.9M | -$116.0M | -$109.6M | -$106.0M | -$97.10M | -$91.75M | -$87.23M |
| Accumulated Other Comp. Income | $11K | -$42K | -$40K | -$50K | -$31K | -$30K | -$38K | -$31K |
| **Total Stockholders' Equity** | $14.67M | $20.68M | $27.76M | $2.38M | $42K | $3.88M | $4.94M | $3.63M |
| Total Equity | $14.67M | $20.68M | $27.76M | $2.38M | $42K | $3.88M | $4.94M | $3.63M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$22.40M | -$23.25M | -$19.77M | -$15.77M | -$12.58M |
| Stock-Based Compensation | $2.63M | $1.91M | $3.09M | $2.32M | $2.72M |
| Change in Receivables | -- | -- | $158K | -$269K | -- |
| Change in Payables | $520K | -$119K | $472K | $211K | $806K |
| **Operating Cash Flow** | -$18.84M | -$15.70M | -$13.07M | -$12.10M | -$4.12M |
| Common Stock Issued | $328K | $659K | -- | $2.47M | $5.74M |
| **Financing Cash Flow** | $17.91M | $18.18M | $9.27M | $12.48M | $14.03M |
| **Net Change in Cash** | -- | $2.45M | -$3.80M | $377K | $9.91M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.18M | -$7.94M | -$6.37M | -$3.63M | -$8.90M | -$5.35M | -$4.52M | -$3.57M |
| Stock-Based Compensation | $882K | $724K | $650K | $811K | $647K | $802K | $371K | $693K |
| Change in Payables | $1.28M | -$145K | $941K | -$1.14M | $1.45M | -$153K | $359K | $369K |
| **Operating Cash Flow** | -$6.31M | -$6.75M | -$5.31M | -$7.02M | -$3.49M | -$4.14M | -$4.20M | -$3.91M |
| Common Stock Issued | -- | -- | -- | -$6.45M | $117K | $61K | $1.52M | -- |
| **Financing Cash Flow** | $0 | -$65K | $31.05M | $4.80M | $4.23M | $3.41M | $5.46M | $4.85M |
| **Net Change in Cash** | -- | -- | -- | -- | -- | -- | $1.26M | $911K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -942.7% | -639.8% | -4140.8% | -- | -- |
| Return on Assets (ROA) | -230.8% | -229.0% | -261.3% | -134.9% | -110.4% |
| Current Ratio | 1.66x | 2.65x | 1.53x | 3.61x | 4.97x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -171.2% | -129.8% | -87.3% | -942.7% | -53610.1% | -417.2% | -398.7% | -639.8% |
| Return on Assets (ROA) | -113.7% | -95.1% | -68.6% | -230.8% | -189.6% | -146.4% | -166.1% | -229.0% |
| Current Ratio | 3.41x | 4.51x | 5.59x | 1.66x | 1.18x | 2.19x | 2.35x | 2.65x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
